Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Morphic Holding, Inc.

MORFNASDAQ
Healthcare
Biotechnology
$56.99
$0.02(0.04%)
U.S. Market opens in 16h 13m

Morphic Holding, Inc. Fundamental Analysis

Morphic Holding, Inc. (MORF) shows weak financial fundamentals with a PE ratio of -15.88, profit margin of -291.93%, and ROE of -29.08%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position29.16%
PEG Ratio-0.16
Current Ratio28.94

Areas of Concern

ROE-29.08%
Operating Margin-342.97%
We analyze MORF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -27372.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-27372.3/100

We analyze MORF's fundamental strength across five key dimensions:

Efficiency Score

Weak

MORF struggles to generate sufficient returns from assets.

ROA > 10%
-21.05%

Valuation Score

Excellent

MORF trades at attractive valuation levels.

PE < 25
-15.88
PEG Ratio < 2
-0.16

Growth Score

Weak

MORF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

MORF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
28.94

Profitability Score

Weak

MORF struggles to sustain strong margins.

ROE > 15%
-2907.73%
Net Margin ≥ 15%
-291.93%
Positive Free Cash Flow
No

Key Financial Metrics

Is MORF Expensive or Cheap?

P/E Ratio

MORF trades at -15.88 times earnings. This suggests potential undervaluation.

-15.88

PEG Ratio

When adjusting for growth, MORF's PEG of -0.16 indicates potential undervaluation.

-0.16

Price to Book

The market values Morphic Holding, Inc. at 3.47 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.47

EV/EBITDA

Enterprise value stands at -16.43 times EBITDA. This is generally considered low.

-16.43

How Well Does MORF Make Money?

Net Profit Margin

For every $100 in sales, Morphic Holding, Inc. keeps $-291.93 as profit after all expenses.

-291.93%

Operating Margin

Core operations generate -342.97 in profit for every $100 in revenue, before interest and taxes.

-342.97%

ROE

Management delivers $-29.08 in profit for every $100 of shareholder equity.

-29.08%

ROA

Morphic Holding, Inc. generates $-21.05 in profit for every $100 in assets, demonstrating efficient asset deployment.

-21.05%

Following the Money - Real Cash Generation

Operating Cash Flow

Morphic Holding, Inc. generates limited operating cash flow of $-133.07M, signaling weaker underlying cash strength.

$-133.07M

Free Cash Flow

Morphic Holding, Inc. generates weak or negative free cash flow of $-134.54M, restricting financial flexibility.

$-134.54M

FCF Per Share

Each share generates $-2.68 in free cash annually.

$-2.68

FCF Yield

MORF converts -3.97% of its market value into free cash.

-3.97%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-15.88

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.16

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.47

vs 25 benchmark

P/S Ratio

Price to sales ratio

5493.87

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.003

vs 25 benchmark

Current Ratio

Current assets to current liabilities

28.94

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.29

vs 25 benchmark

ROA

Return on assets percentage

-0.21

vs 25 benchmark

ROCE

Return on capital employed

-0.26

vs 25 benchmark

How MORF Stacks Against Its Sector Peers

MetricMORF ValueSector AveragePerformance
P/E Ratio-15.8829.43 Better (Cheaper)
ROE-29.08%800.00% Weak
Net Margin-29192.90%-20145.00% (disorted) Weak
Debt/Equity0.000.30 Strong (Low Leverage)
Current Ratio28.944.64 Strong Liquidity
ROA-21.05%-17936.00% (disorted) Weak

MORF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Morphic Holding, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ